Backs FY25 revenue view flat to up 3%. The company said, “While reported and organic net sales growth are expected to be towards the lower end of their respective ranges, due primarily to infant formula industry dynamics and market consumption trends, the Company reaffirms all of its full-year 2025 financial targets.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRGO:
- PRGO Upcoming Earnings Report: What to Expect?
- Perrigo’s Strategic Divestiture: Strengthening Core Operations and Enhancing Shareholder Value
- Perrigo Sells Dermacosmetics Business for €327 Million
- Perrigo to sell Dermacosmetics business for up to EUR 327M
- Perrigo Company’s Strategic Enhancements and FY25 Guidance Reinforce Buy Rating